(19)
(11) EP 4 278 015 A1

(12)

(43) Date of publication:
22.11.2023 Bulletin 2023/47

(21) Application number: 22701188.9

(22) Date of filing: 13.01.2022
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6886; C12Q 2600/178; C12Q 2600/158; C12Q 2600/156; C12Q 2600/154; C12Q 2600/112
(86) International application number:
PCT/EP2022/050625
(87) International publication number:
WO 2022/152784 (21.07.2022 Gazette 2022/29)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.01.2021 EP 21151746

(71) Applicant: HealthBioCare GmbH
1090 Wien (AT)

(72) Inventors:
  • TOMEVA, Elena
    1090 Wien (AT)
  • HASLBERGER, Alexander
    1130 Wien (AT)
  • HIPPE, Berit
    1180 Wien (AT)
  • SCHMID, Juerg Daniel
    8832 Wollerau (CH)
  • SWITZENY, Olivier
    1040 Wien (AT)
  • HEITZINGER, Clemens
    1190 Wien (AT)

(74) Representative: Banse & Steglich Patentanwälte PartmbB 
Patentanwaltskanzlei Herzog-Heinrich-Straße 23
80336 München
80336 München (DE)

   


(54) METHODS FOR DETERMINING CANCER